Burger Charles D, Foreman Aimee J, Miller Dave P, Safford Robert E, McGoon Michael D, Badesch David B
Division of Pulmonary Medicine, Mayo Clinic, 4500 San Pablo Rd., Jacksonville, FL 32224, USA.
Mayo Clin Proc. 2011 Feb;86(2):105-12. doi: 10.4065/mcp.2010.0394.
To investigate the correlation between body mass index (BMI) and pulmonary artery systolic pressure in a large population of patients with pulmonary arterial hypertension (PAH).
The BMI of patients with group 1 PAH enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management (REVEAL) was compared with that of age- and sex-matched controls in the National Health and Nutrition Examination Survey (NHANES) to clarify whether obesity is linked with PAH. The diagnosis of PAH was defined in REVEAL by right-sided heart catheterization. Differences in BMI and the percentage of patients considered obese (BMI ≥30) and underweight (BMI <18.5) in various subgroups of patients enrolled in REVEAL from March 30, 2006, through September 11, 2007, were determined.
Mean BMI was no different for patients with PAH (n=2141) than for the NHANES normal comparison group; however, the proportion of obese and underweight patients was increased in patients with PAH. Subgroup analysis demonstrated that subgroups with idiopathic PAH and those with PAH associated with drugs and toxins had both higher BMI and percentage of obese patients, whereas 3 other subgroups (those with PAH associated with congenital heart disease, connective tissue disease, and human immunodeficiency virus) had lower mean BMI.
Mean BMI of the REVEAL patients was the same as that of the NHANES normal comparison group; however, there were higher percentages of obese and underweight patients in REVEAL. This discrepancy can be explained by the balancing effect of more overweight and underweight patients in different PAH subgroups. The reason for the increased frequency of obesity in idiopathic PAH is unknown, and additional study is needed.
在大量肺动脉高压(PAH)患者中研究体重指数(BMI)与肺动脉收缩压之间的相关性。
将纳入评估早期和长期PAH疾病管理注册研究(REVEAL)的1组PAH患者的BMI与美国国家健康和营养检查调查(NHANES)中年龄和性别匹配的对照组进行比较,以明确肥胖是否与PAH相关。REVEAL中PAH的诊断通过右心导管检查确定。确定了2006年3月30日至2007年9月11日纳入REVEAL的不同亚组患者中BMI的差异以及被视为肥胖(BMI≥30)和体重过轻(BMI<18.5)患者的百分比。
PAH患者(n=2141)的平均BMI与NHANES正常对照组无差异;然而,PAH患者中肥胖和体重过轻患者的比例有所增加。亚组分析表明,特发性PAH亚组以及与药物和毒素相关的PAH亚组的BMI和肥胖患者百分比均较高,而其他3个亚组(与先天性心脏病、结缔组织病和人类免疫缺陷病毒相关的PAH亚组)的平均BMI较低。
REVEAL患者的平均BMI与NHANES正常对照组相同;然而,REVEAL中肥胖和体重过轻患者的百分比更高。这种差异可以通过不同PAH亚组中更多超重和体重过轻患者的平衡作用来解释。特发性PAH中肥胖发生率增加的原因尚不清楚,需要进一步研究。